GLP-1 Weight Loss in Wilmington, DE: One of 13 States That Cover It, and No Local Cash Price
Wilmington's 41.0% obesity rate against Delaware's 35.7%, a 43,207:1 low-income HPSA ratio, Delaware Medicaid's obesity coverage, and three local providers with no published price.
Wilmington's adult obesity prevalence is 41.0% (CDC PLACES 2025 release, BRFSS 2023) 1 against Delaware's statewide 35.7% 3, with New Castle County sitting between them 2. That 5.3-point gap over the state is the widest in this batch, and it is real.
The city's 73,173 residents form a small core inside the Philadelphia-Camden-Wilmington metro of 6,272,014 467, with a 10.1% uninsured rate and a $65,389 median household income 4. Delaware does cover GLP-1s for obesity through Medicaid 9. What no Wilmington provider will do is post a cash price 101112.
New Castle County — the county Wilmington sits in — carries an active HRSA Primary Care HPSA population designation, "LI - Wilmington/Stanton/Newark" (HPSA ID 1104101027; designated 10/24/2025; score 16; approximately 87,969 people in the low-income population group; population-to-provider ratio approximately 43,207:1). Two Wilmington-based FQHCs carry their own facility-level Primary Care HPSA designations: Westside Family Healthcare Inc (score 21, 300 Water St Ste 200) and Southbridge Medical Advisory Council Inc (score 20, 601 New Castle Ave), both originally designated 11/21/2003 and last updated 09/22/2025. Source: HRSA Bureau of Health Workforce, Primary Care HPSA bulk data file, extract dated 08/27/2026.8
Specialist access
HRSA's shortage designations only cover primary care, dental, and mental health — there is no federal shortage category for endocrinology or obesity medicine specifically, so specialist bench strength has to be read qualitatively. ChristianaCare, Delaware's dominant health system with its Wilmington Hospital campus inside the city, runs the region's main clinical Weight Care and Management program plus a bariatric-surgery track, but routes patients through an insurance-based referral pathway rather than posting self-pay access or pricing. Outside that system, Wilmington's two FQHCs — Westside Family Healthcare and Southbridge Medical Advisory Council — are the real safety-net primary-care access points, and both are already HRSA-flagged as underserved. Net effect: a Wilmington adult without insurance or a ChristianaCare referral has very little visible specialist pathway to GLP-1 prescribing inside the city limits, which is exactly the gap telehealth access is built to close.8
Medicaid coverage note
As of January 2026, Delaware IS one of 13 state Medicaid programs (DE, KS, MA, MI, MN, MS, MO, NC, RI, TN, UT, VA, WI) with fee-for-service coverage in place for GLP-1s prescribed specifically for obesity treatment, per KFF's Medicaid GLP-1 tracker (kff.org, last updated Jan 16, 2026 — confirmed against the page's own underlying state-by-state dataset, not just its narrative summary). This is the obesity/weight-loss indication only; standard Medicaid coverage for type-2-diabetes prescribing (e.g., Ozempic or Mounjaro for a diabetic patient) is separate, broader, and not in question here. No Delaware-specific DMMA or other state .gov policy document detailing prior-authorization criteria, the exact covered-drug list, or an effective date was locatable this session (DMMA pharmacy/PDL pages returned 404s) — so treat this as a KFF-sourced, dated fact that coverage exists, not a quoted Delaware statute. Patients should confirm current prior-authorization requirements directly with Delaware Medicaid (DMMA).9
Delaware is one of 13 state Medicaid programs covering GLP-1s for obesity
As of January 2026, Delaware is among the 13 state Medicaid programs (DE, KS, MA, MI, MN, MS, MO, NC, RI, TN, UT, VA, WI) with fee-for-service coverage in place for GLP-1s prescribed specifically for obesity, per KFF's Medicaid GLP-1 tracker, last updated January 16, 2026 and confirmed against the page's underlying state-by-state dataset rather than its narrative summary 9.
That is the obesity indication only; type 2 diabetes prescribing is separate and broader. No Delaware DMMA or other state policy document detailing prior-authorization criteria, the covered-drug list, or an effective date was locatable this session, as DMMA pharmacy and PDL pages returned 404s. Treat this as a dated, KFF-sourced fact that coverage exists, not as a quoted Delaware rule, and confirm current PA requirements with DMMA directly.
What GLP-1 care costs in Wilmington today
First State Med Spa at 1300 N Franklin St runs a physician-led "Supervised Medical Weight Loss" program described as using "advanced, legally sourced therapies to assist with appetite regulation and metabolic function," and explicitly states it does not use compounded versions. It names no drug and posts no price, dose, or program length anywhere; cost is quote-only 10.
ChristianaCare, whose Wilmington Hospital campus sits inside the city, runs the region's main clinical weight-management program plus a bariatric-surgery track, and publishes no self-pay price, cash rate, or program fee on the program page; the pathway is insurance-referral based 11. Pure Wellness Chiropractic at 2106 Silverside Rd markets a weight-loss line in its branding and footer but names no GLP-1 drug and posts no price 12.
For an uninsured Wilmington adult, that means three doors and no numbers. Astra's price is national and identical everywhere it is licensed: $68/month for compounded semaglutide and $118/month for compounded tirzepatide, both on 12-month plans billed annually at $816 and $1,416. There is no Wilmington rate, no local discount, and no consult required to find out the number.
A 43,207:1 ratio for the city's low-income population
New Castle County carries an active HRSA Primary Care HPSA population designation, "LI - Wilmington/Stanton/Newark" (HPSA ID 1104101027, designated 10/24/2025, score 16), covering approximately 87,969 people in the low-income population group at a population-to-provider ratio of approximately 43,207:1 8. Two Wilmington FQHCs carry their own facility designations: Westside Family Healthcare at 300 Water St Ste 200 (score 21) and Southbridge Medical Advisory Council at 601 New Castle Ave (score 20), both originally designated 11/21/2003 and last updated 09/22/2025 8.
There is no federal shortage category for endocrinology or obesity medicine, so specialist depth has to be read qualitatively. ChristianaCare dominates, and it routes patients through insurance-based referral rather than posting self-pay access. Outside it, the two HRSA-flagged FQHCs are the real safety-net entry points.
The net effect is that a Wilmington adult without insurance or a ChristianaCare referral has very little visible pathway to a GLP-1 prescriber inside city limits. That is precisely the gap telehealth closes. Astra serves all 50 states, including Delaware.
Astra treats patients in Delaware through state-licensed physicians.
Local options
First State Med Spa — Med spa at 1300 N Franklin St, Wilmington runs a physician-led "Supervised Medical Weight Loss" program described as using "advanced, legally sourced therapies to assist with appetite regulation and metabolic function" and explicitly states it does not use compounded versions — but names no drug and posts no price, dose, or program-length figure anywhere on the site; cost is quote-only via phone or consult. https://firststatemedspa.com/medical-weight-loss/(checked 2026-08-28)
ChristianaCare — Weight Care and Management — Delaware's largest health system (its Wilmington Hospital campus sits inside the city) runs the region's main clinical weight-management program plus a separate bariatric-surgery track. No self-pay GLP-1 price, cash rate, or program fee is published anywhere on the program page; the pathway described is insurance-referral based, not a posted cash price. https://www.christianacare.org/us/en/wellness/weight-care-and-management(checked 2026-08-28)
Pure Wellness Chiropractic, Acupuncture, Massage, and Weight Loss — Chiropractic practice at 2106 Silverside Rd, Wilmington markets a "weight loss" service line in its branding and footer copy, but its own site names no GLP-1 drug (no semaglutide/tirzepatide) and posts no price for any weight-loss program. https://purewellchiro.com/(checked 2026-08-28)
Frequently asked questions
Is Astra cheaper than local GLP-1 options in Wilmington, DE?
We can't say for certain, because there's no local price to compare against — none of the three Wilmington providers we checked (First State Med Spa, ChristianaCare's Weight Care and Management program, and Pure Wellness Chiropractic & Weight Loss) publishes a GLP-1 price anywhere on its site. Astra's price is public and the same everywhere it's licensed: $68/mo for semaglutide or $118/mo for tirzepatide, each on a 12-month plan ($816 or $1,416 total). If a Wilmington clinic won't quote a number without a phone call or consult first, that's worth knowing before you commit to one.
Does Delaware Medicaid cover Wegovy, Ozempic, or Zepbound for weight loss?
As of January 2026, yes for the obesity indication specifically — Delaware is one of 13 state Medicaid programs with fee-for-service coverage in place for GLP-1s prescribed for obesity treatment, per KFF's Medicaid GLP-1 tracker (Jan 16, 2026). That's separate from GLP-1 coverage for type 2 diabetes, which is more broadly available already. We couldn't locate a Delaware DMMA policy document spelling out prior-authorization rules or the exact covered-drug list, so confirm current eligibility and requirements directly with Delaware Medicaid before assuming a specific prescription is covered.
Why don't Wilmington weight-loss clinics post their GLP-1 prices online?
We checked three Wilmington providers with weight-loss offerings — First State Med Spa, ChristianaCare's Weight Care and Management program, and Pure Wellness Chiropractic & Weight Loss — and as of Aug 28, 2026, none publishes a price, dose, or program-length figure for GLP-1 treatment anywhere on its site. First State Med Spa quotes cost only by phone or consult; ChristianaCare's pathway runs through insurance referral rather than a posted cash rate; Pure Wellness doesn't name a GLP-1 drug at all. That opacity is itself the finding — there's no verifiable 'going rate' in Wilmington to publish.
What metro area is Wilmington, Delaware actually part of?
Wilmington sits in New Castle County, which is itself the official "Wilmington, DE-MD-NJ" Metropolitan Division (OMB code 48864, pairing New Castle County with Cecil County, MD and Salem County, NJ) — nested inside the much larger Philadelphia-Camden-Wilmington, PA-NJ-DE-MD metro area (6.27 million people). Delaware has only three counties and no independent tier-2 metro of its own, so Wilmington's metro status is borrowed entirely from Philadelphia. That surrounding area is also considerably better off than the city itself: New Castle County's median household income ($91,166) runs about 39% above Wilmington's own ($65,389).
Is Wilmington's obesity rate higher than the rest of Delaware?
Yes. Wilmington's crude adult obesity rate is 41.0% (CDC PLACES, 2025 release, BRFSS 2023 data) — about 5 points above Delaware's statewide rate of 35.7% (CDC BRFSS) and roughly 8 points above New Castle County's own rate of 33.4% (same CDC PLACES release). The city carries a meaningfully heavier burden than either the county that contains it or the state as a whole.
Sources
CDC PLACES: Local Data for Better Health, Place Data, 2025 release (city obesity + insurance, BRFSS 2023) — dataset eav7-hnsx — https://data.cdc.gov/d/eav7-hnsx
CDC PLACES: Local Data for Better Health, County Data, 2025 release (New Castle County obesity + insurance, BRFSS 2023) — dataset swc5-untb — https://data.cdc.gov/d/swc5-untb